GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cyp1a2 | multiple interactions | EXP | | 6480464 | CTD | [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with Hemin] results in decreased expression of CYP1A2 protein; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A2 protein; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein; [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A2 protein; Hemin inhibits the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in decreased expression of CYP1A2 protein]; Hemin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of CYP1A2 protein]; Oxygen deficiency affects the reaction [CYP1A2 protein results in increased metabolism of aristolochic acid I]; Oxygen inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 mRNA] | PMID:24657529 PMID:26747958 PMID:26845733 | Cyp1a2 | decreases expression | ISO | CYP1A2 (Homo sapiens) | 6480464 | CTD | Oxygen deficiency results in decreased expression of CYP1A2 mRNA | PMID:19695866 | Cyp1a2 | increases activity | ISO | Cyp1a2 (Mus musculus) | 6480464 | CTD | Oxygen results in increased activity of CYP1A2 protein | PMID:21745492 | Cyp1a2 | increases expression | ISO | Cyp1a2 (Mus musculus) | 6480464 | CTD | Oxygen results in increased expression of CYP1A2 mRNA | PMID:25703676 | Cyp1a2 | increases expression | ISO | CYP1A2 (Homo sapiens) | 6480464 | CTD | Oxygen deficiency results in increased expression of CYP1A2 mRNA | PMID:33811995 | Cyp1a2 | increases response to substance | ISO | CYP1A2 (Homo sapiens) | 6480464 | CTD | CYP1A2 gene mutant form results in increased susceptibility to Oxygen | PMID:29180065 | Cyp1a2 | multiple interactions | ISO | Cyp1a2 (Mus musculus) | 6480464 | CTD | [beta-Naphthoflavone results in increased expression of CYP1A2 protein] inhibits the reaction [CYP1A1 gene mutant form results in increased susceptibility to Oxygen]; [beta-Naphthoflavone results in increased expression of CYP1A2 protein] which results in decreased susceptibility to Oxygen; [Quercetin co-treated with Oxygen] results in increased expression of CYP1A2 mRNA; beta-Naphthoflavone promotes the reaction [Oxygen results in increased activity of CYP1A2 protein]; beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A2 mRNA]; Oxygen inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein]; Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 mRNA] | PMID:21745492 PMID:28201809 PMID:29180065 PMID:29432836 | Cyp1a2 | multiple interactions | ISO | CYP1A2 (Homo sapiens) | 6480464 | CTD | [CYP1A2 gene mutant form results in increased susceptibility to Oxygen] which results in increased expression of NQO1 mRNA; CYP1A2 gene mutant form inhibits the reaction [beta-Naphthoflavone promotes the reaction [Oxygen results in increased expression of CYP1A1 mRNA]]; CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]]; CYP1A2 gene mutant form inhibits the reaction [Oxygen promotes the reaction [beta-Naphthoflavone results in increased expression of NQO1 protein]]; Oxygen deficiency affects the reaction [CYP1A2 protein results in increased metabolism of aristolochic acid I]; Oxygen deficiency affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA]; Oxygen deficiency inhibits the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA]; Oxygen deficiency inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 mRNA] | PMID:26845733 PMID:29180065 PMID:33811995 | |
Go Back to source page | Continue to Ontology report |